Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer
Clinical trial NCT01239342 · TERMINATED
Trial details
- NCT number
- NCT01239342
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-27
- Primary completion
- 2018-09-19
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.